Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Newborns whose mothers have not received the RSV vaccine should receive nirsevimab between October and March. If you do become sick, you can reduce transmission of viruses by staying away from others ...

RSV cases drop in Alaska's Yukon-Kuskokwim region, Ketchikan airport parking is tight, hunters urged to try lead-free ammo, ...

RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in ...

CHICAGO The Illinois Department of Public Health (IDPH) announced that the state’s overall respiratory illness level has ...

CHICAGO – The Illinois Department of Public Health (IDPH) announced that the state’s overall respiratory illness level has ...

HealthDay News — The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA Pediatrics.

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

One is COVID-19. Another is RSV, or respiratory syncytial virus, which is a common cause of cold-like symptoms but can be dangerous for infants and the elderly. The most recent CDC data show COVID ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Though there are now respiratory syncytial virus (RSV) vaccines approved by the FDA and recommended by the CDC for ...